2021
DOI: 10.1016/j.blre.2021.100864
|View full text |Cite
|
Sign up to set email alerts
|

Coagulopathy and sepsis: Pathophysiology, clinical manifestations and treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
56
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 66 publications
(60 citation statements)
references
References 108 publications
0
56
0
Order By: Relevance
“…The patients accompanied with AF were older than that of patients without AF (70, 63-76 vs. 58, 48-69; P < 0.001). Furthermore, stroke (0.76 vs. 3.30%; P < 0.001), CHF (16.23 vs. 41.43%; P < 0.001), hypertension (43.90 vs. 56.48%; P < 0.001), diabetes (24.47 vs. 35.32%; P < 0.001), ECI (11,(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17) vs. 17.12-22; P < 0.001), APS III (49, 37-63 vs. 53, 42-67; P < 0.001), INR (1.3, 1.2-1.7 vs. 1.5, 1.2-2.2; P < 0.001), and APTT (32.7, 27.7-43.9, vs. 34.6, 29-46.1; P < 0.001) were significantly different in patients between the AF and non-AF groups. Among septic patients, the AF group had higher in-hospital mortality and 90-day mortality (19.71 vs. 13.79%, P < 0.001; 59.21 vs. 56.04%, P = 0.001).…”
Section: Demographic and Baseline Characteristicsmentioning
confidence: 99%
See 1 more Smart Citation
“…The patients accompanied with AF were older than that of patients without AF (70, 63-76 vs. 58, 48-69; P < 0.001). Furthermore, stroke (0.76 vs. 3.30%; P < 0.001), CHF (16.23 vs. 41.43%; P < 0.001), hypertension (43.90 vs. 56.48%; P < 0.001), diabetes (24.47 vs. 35.32%; P < 0.001), ECI (11,(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17) vs. 17.12-22; P < 0.001), APS III (49, 37-63 vs. 53, 42-67; P < 0.001), INR (1.3, 1.2-1.7 vs. 1.5, 1.2-2.2; P < 0.001), and APTT (32.7, 27.7-43.9, vs. 34.6, 29-46.1; P < 0.001) were significantly different in patients between the AF and non-AF groups. Among septic patients, the AF group had higher in-hospital mortality and 90-day mortality (19.71 vs. 13.79%, P < 0.001; 59.21 vs. 56.04%, P = 0.001).…”
Section: Demographic and Baseline Characteristicsmentioning
confidence: 99%
“…Coagulation dysfunction, including SIC and DIC, are common complications in sepsis ( 7 ). After being triggered by an acute systemic inflammatory response of sepsis, coagulation initiates and induces extensive crosstalk with inflammation and immunity to promote SIC and DIC ( 8 , 9 ).…”
Section: Introductionmentioning
confidence: 99%
“…Although sepsis is one of the most common causes of thrombocytopenia in critically ill patients, several other causes can mimic sepsis-related thrombocytopenia, such as myelodysplastic syndrome and aplastic anemia, as well as drugs, such as thiazide or chemotherapics, which inhibit platelet production [97].…”
Section: Plateletsmentioning
confidence: 99%
“…After the vascular wall is damaged, vascular endothelial cells, neutrophils, monocytes and platelets can express and release tissue factor, and then activate the coagulation system [39]. In addition, the release of inflammatory mediators after sepsis and the direct binding of activated immune cells to platelets activate platelets, resulting in abnormal coagulation function [40]. Tian et al demonstrated that the surface of BDEV carries tissue factor, and BDEVs promoted the expression of PS on the platelet surface after binding with platelets.…”
Section: Discussionmentioning
confidence: 99%